Anti-LILRB4/CD85K(Rolistobart Biosimilar) Antibody

Details and Advantages

Code: 400-429-001

Specification:

Applications: ELISA,Flow Cyt

Reactivity: Human LILRB4/CD85K

Conjugate: Unconjugated

Advantages:

High lot-to-lot consistency Increased sensitivity and higher affinity Animal-free production

Product Description Manual MSDS FAQ Citations

Product Detail

Description:
Anti-LILRB4/CD85K(Rolistobart Biosimilar) Antibody is a biosimilar antibody directed against Human LILRB4/CD85K.

Isotype: Human IgG4
Conjugate: Unconjugated
Specificity: Human LILRB4/CD85K
Clonality: Monoclonal
Purity: Recombinant Expression and Affinity purified
Concentration: 1mg/ml
Formation: Liquid, 10mM PBS (pH 7.5)
Storage: Store at –20 °C, (Avoid freeze/thaw cycles)

FAQ

Citations

Related Products

Anti-KDR/VEGFR2(Ramucirumab Biosimilar) Antibody

Anti-Misfolded TTR(Coramitug Biosimilar) Antibody

Anti-TIGIT/VSTM3(Ociperlimab Biosimilar) Antibody

Anti-APP(Lecanemab Biosimilar) Antibody

Anti-Heat Shock Protein 90 Homolog(Efungumab Biosimilar) Antibody

Anti-TNF/TNFA(Adalimumab Biosimilar) Antibody

Anti-CD40/TNFRSF5(Bleselumab Biosimilar) Antibody

Anti-CEACAM5/CD66e(Tusamitamab Biosimilar) Antibody